Join global leaders in science and healthcare at WPST 2026, the World Pharmaceutical Sciences & Translational Congress, organized by Mathews Conferences. This premier international event brings together researchers, academicians, clinicians, and industry professionals to explore innovations shaping the future of pharmaceuticals and translational medicine.
🌍 World Pharmaceutical Sciences
& Translational Congress 2026
Theme: Bridging Discovery,
Development, and Patient Care
Abstract Submissions Now Open for WPST 2026
Exciting Announcement!
Abstract submissions are now OPEN for the World
Pharmaceutical Sciences & Translational Congress 2026 (WPST 2026),
proudly hosted by Mathews Conferences.
This prestigious international congress invites researchers, academicians,
healthcare professionals, and industry experts to present their latest
research and innovations in pharmaceutical sciences. Participants can
join in person in Boston, Massachusetts, USA, or virtually
from anywhere in the world.
🌍 About the Congress
WPST 2026 will serve as a global platform showcasing the latest
breakthroughs in pharmaceutical sciences and translational research.
The scientific program will feature:
✔ Keynote presentations by leading experts
✔ Oral and poster presentation sessions
✔ Interactive workshops and panel discussions
✔ Valuable networking and collaboration opportunities
📝 Abstract Submission
Researchers are encouraged to submit their abstracts and be part of this
impactful scientific gathering.
👉 Submit your abstract here:
🔗 https://pharmaceuticalsciencesconference.com/abstract-submission
Don’t miss this opportunity to showcase your findings, share
insights, and connect with a global scientific community dedicated to
advancing pharmaceutical research and innovation.
📌 Conference Details
📅 Dates: October 26–28, 2026
📍 Venue: Boston,
Massachusetts, USA & Online
🎯 Theme: Translating Science
into Safer, Smarter Therapeutics
📲 WhatsApp: +1 (424) 377
0967
Submit your abstract today and secure your place at WPST 2026—where
science meets innovation.
No comments:
Post a Comment